News

Photo
News

Carbios Postpones Construction of PET Bio-Recycling Facility in France

French green chemistry company Carbios announced that it is postponing the construction of its PET bio-recycling plant in Longlaville for six to nine months due to delayed funding pending completion of additional financing under satisfactory conditions. The company aims to complete the financing as soon as possible to meet market needs from 2027. Carbios expects to sign several binding commercial contracts in the first half of 2025.

Photo
News

Merck & Co. Licenses Obesity Drug from Hansoh Pharma

US Merck & Co., operating as MSD outside the US and Canada, and Chinese biopharmaceutical company Hansoh Pharma have entered into an exclusive global license agreement for HS-10535, an investigational preclinical oral small molecule GLP-1 receptor agonist. GLP-1 receptor agonists are primarily used for the treatment of type 2 diabetes and obesity.

Photo
News

AbbVie to Buy Nimble Therapeutics for $200 Million

US biopharma AbbVie has signed an agreement to acquire US biotechnology company Nimble Therapeutics, including its lead asset, an investigational oral peptide IL23R inhibitor in preclinical development for the treatment of psoriasis and a pipeline of other novel oral peptide candidates with potential across several autoimmune diseases.

Photo
News

Newron Licenses Schizophrenia Treatment to EA Pharma

Italian drugmaker Newron Pharmaceuticals and EA Pharma, a subsidiary of Japan’s Eisai, today have entered into a license agreement to develop, manufacture and commercialize Newron’s evenamide in Japan and other designated Asian territories.

Photo
News • Pharma

Austria: A Hotspot for Life Sciences

An Attractive and Highly Sought-after Business Location

The life sciences sector, encompassing biotechnology, pharmaceuticals and medical technology, is developing rapidly in Austria.

Photo
Sponsored • News • Strategy

Substantial Progresses in Sustainability Focus Areas

The Italian Olon Group, a leading international supplier of active pharmaceutical ingredients (APIs), presents the 2023 Corporate Sustainability Report and confirms the sustainability journey toward energy transition, investments in alternative energy sources, social and economic involvement and support for the communities in which it operates

Photo
News

Greensand CCS Project Partners Take Final Investment Decision

Ineos and its partners Harbour Energy and Nordsøfonden have taken the final investment decision (FID) into the first commercial phase ‘Greensand Future’ with storage operations in a depleted oil field in the Danish North Sea set to begin at the end of 2025/early 2026.

Photo
News

Samabriva Opens Biomanufacturing Facility in Belgium

French biotechnology company Samabriva has opened a new 1,400 m2 biomanufacturing facility in Liege, Belgium. The multi-million Euros investment is designed to provide industrial-scale production of high-value natural molecules used in the manufacture of pharmaceutical products, the company said.

Photo
News • Bioprocessing

Amgen Plans $1 Billion Manufacturing Expansion in North Carolina

In a move to expand its global biomanufacturing network, US biopharma Amgen is planning to invest $1 billion to build a second drug substance manufacturing facility at its US site in Holy Springs, North Carolina. This brings the company's total planned investment in Holly Springs to more than $1.5 billion, building on its previously announced $550 million commitment.

Photo
News • Strategy

Navigating the Future of Chemical Distribution

In 2024, the chemical distribution industry is at a pivotal moment, navigating both challenges and new opportunities. As distributors grapple with a landscape shaped by shifting global trade routes, demand constraints, and digital disruption, their roles are evolving far beyond traditional bulk breaking.

Photo
News • Strategy

Doppelganger Plastics: A More Desirable Alternative?

Plastics are highly effective but environmentally damaging. PET is a prime example, being cheap and recyclable yet oil-based. With plastics set to consume 20% of global oil and gas by 2050, sustainable alternatives are crucial. Enter PEF, a bioplastic that could revolutionize the industry. Can PEF be the solution we need?

Photo
News • Strategy

CSDDD: The Formula for a Sustainable Chemical Industry?

The EU's Corporate Sustainability Due Diligence Directive (CSDDD) is reshaping the chemical industry's approach to environmental and social responsibility. A close look at the requirements reveals significant changes to supply chain oversight, risk management, and sustainability reporting. Chemical companies must implement new strategies to ensure compliance, drive innovation, and adapt to evolving regulations.

Photo
News • Strategy

Transforming Distribution Strategies

Experts of Ataman Chemicals, Barentz, Biesterfeld, Brenntag, BÜFA Chemicals, CSC Jaeklechemie, Häffner, IMCD, Krahn Chemie, Möller Chemie, Nordmann, RN Chemicals, and Stockmeier share their opinions

Photo
News • Strategy

Statement: Dany Njeim, CEO, RN Chemicals

CHEManager asked executives and industry experts from a broad range of chemical distributors to share their views on how their companies are dealing with this changing economic environment and the resulting opportunities and challenges.

Photo
News • Strategy

Statement: Thomas Dassler, CEO, Häffner

CHEManager asked executives and industry experts from a broad range of chemical distributors to share their views on how their companies are dealing with this changing economic environment and the resulting opportunities and challenges.

Photo
News • Strategy

Statement: Rolf Kuropka, CEO, Krahn Chemie Group

CHEManager asked executives and industry experts from a broad range of chemical distributors to share their views on how their companies are dealing with this changing economic environment and the resulting opportunities and challenges.

Photo
News • Strategy

Statement: Lars Schneider, EMEA CEO, Barentz

CHEManager asked executives and industry experts from a broad range of chemical distributors to share their views on how their companies are dealing with this changing economic environment and the resulting opportunities and challenges.

Photo
News • Strategy

Statement: Stephan Glander, CEO, Biesterfeld

CHEManager asked executives and industry experts from a broad range of chemical distributors to share their views on how their companies are dealing with this changing economic environment and the resulting opportunities and challenges.

13436 more News

Top-Feature

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.